Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC
Conditions : Esophageal Squamous Cell Carcinoma Interventions : Drug: Becotatug Vedotin Combined with Cisplatin and Concurrent Radiotherapy Sponsors : Hebei Medical University Fourth Hospital Not yet…
Read the full article17h agoen
You might also wanna read
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in p
Medscape·2d ago
El V Oncocongreso de Alicante abordará los últimos avances en el tratamiento contra el cáncer
El evento tendrá lugar el 28 de noviembre para poner en el centro del debate la atención multidisciplinar a pacientes oncológicos
todoalicante.es·8h ago
El V Oncocongreso de Alicante abordará los últimos avances en el tratamiento contra el cáncer
El evento tendrá lugar el 28 de noviembre para poner en el centro del debate la atención multidisciplinar a pacientes oncológicos
todoalicante.es·8h ago
Disitamab Vedotin, Tislelizumab, and S-1 Deliver High Response Rates in HER2-Overexpressing Advanced Gastric/GEJ Cancer
HER2-targeted therapy has improved outcomes in advanced gastric and gastroesophageal junction adenocarcinoma, but resistance and heterogeneo
OncoDaily·2h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.